we conclude that islet a- and b-cell responses to nonglucose secretogogues are abnormal in patients with niddm and that this may result from a functional defect in the modulating effect of glucose on insulin and glucagon secretion , which in some patients may be compensated for by hyperglycemia .
C0011860
niddm
C0021641
insulin